Mp40-10 Extended Validation Results From a Prospective Adaptive Utility Trial Confirm Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-Grade Prostate Cancer at Initial Biopsy
Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.1277
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)